- Home
- VICI vs BNTX Comparison
VICI vs BNTX Comparison
Compare VICI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VICI | BNTX |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.7B | 25.5B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | VICI | BNTX |
|---|---|---|
| Price | $29.52 | $102.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 11 |
| Target Price | $34.00 | ★ $140.31 |
| AVG Volume (30 Days) | ★ 7.5M | 541.7K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | ★ 6.07% | N/A |
| EPS Growth | ★ 1.95 | N/A |
| EPS | ★ 2.61 | N/A |
| Revenue | ★ $4,006,116,000.00 | N/A |
| Revenue This Year | $4.59 | $2.54 |
| Revenue Next Year | $1.72 | N/A |
| P/E Ratio | $11.32 | ★ N/A |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $27.03 | $90.12 |
| 52 Week High | $34.01 | $124.00 |
Technical Indicators
Market Signals| Indicator | VICI | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.40 | 42.13 |
| Support Level | $28.94 | $99.63 |
| Resistance Level | $30.66 | $113.12 |
| Average True Range (ATR) | 0.51 | 3.26 |
| MACD | -0.10 | -1.01 |
| Stochastic Oscillator | 38.02 | 34.58 |
Price Performance
Historical ComparisonAbout VICI VICI Properties Inc.
VICI Properties Inc is a real estate investment trust based in the United States. It engaged in the business of owning and acquiring gaming, hospitality, wellness, entertainment and leisure destinations, subject to long-term triple net leases. It own nearly 93 experiential assets across a geographically portfolio consisting of nearly 54 gaming properties and nearly 39 other experiential properties across the United States and Canada, including Caesars Palace Las Vegas, MGM Grand and the Venetian Resort Las Vegas.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.